Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
Davide Moi, Alessio Nocentini, Alessandro Deplano, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111638-111638
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 412-412
Open Access | Times Cited: 137
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110099-110099
Closed Access | Times Cited: 13
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors
Shubham Kumar, Sandeep Rulhania, Shalini Jaswal, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112923-112923
Closed Access | Times Cited: 114
Recent advancements in the development of bioactive pyrazoline derivatives
Bhupender Nehra, Sandeep Rulhania, Shalini Jaswal, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112666-112666
Closed Access | Times Cited: 107
A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents
Kashif Haider, Mohd Shafeeque, Shaikh Yahya, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100042-100042
Open Access | Times Cited: 42
Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes
Cem Yamalı, Halise İnci Gül, Cavit Kazaz, et al.
Bioorganic Chemistry (2020) Vol. 96, pp. 103627-103627
Closed Access | Times Cited: 65
Synthetic aspects, structural insights and pharmacological potential of pyrazole derivatives: an overview
Regina Menezes, K. Subrahmanya Bhat
Deleted Journal (2025) Vol. 7, Iss. 2
Open Access
Novel adamantane-pyrazole and hydrazone hybridized: Design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors
Mohammed M. S. Wassel, Ahmed Ragab, Gameel A. M. El‐Hag Ali, et al.
Journal of Molecular Structure (2020) Vol. 1223, pp. 128966-128966
Closed Access | Times Cited: 45
Design and synthesis of novel pyrazoline derivatives for their spectroscopic, single crystal X-ray and biological studies
Mohammad Asad, Salman A. Khan, Muhammad Nadeem Arshad, et al.
Journal of Molecular Structure (2021) Vol. 1234, pp. 130131-130131
Closed Access | Times Cited: 26
Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases
Gonca Çelik, Tayfun Arslan, Murat Şentürk, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 3
Closed Access | Times Cited: 25
Discovery of a New Class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as Human Carbonic Anhydrase Inhibitors
Davide Moi, Serena Vittorio, Andrea Angeli, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 470-477
Open Access | Times Cited: 2
Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors
Bengt‐Harald Jonsson, Anders Liljas
Biophysical Journal (2020) Vol. 119, Iss. 7, pp. 1275-1280
Open Access | Times Cited: 22
Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Biophysical Journal (2020) Vol. 120, Iss. 1, pp. 178-181
Open Access | Times Cited: 19
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors
Davide Moi, Alessio Nocentini, Alessandro Deplano, et al.
Bioorganic Chemistry (2020) Vol. 98, pp. 103728-103728
Closed Access | Times Cited: 17
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors
Alessio Nocentini, Davide Moi, Alessandro Deplano, et al.
European Journal of Medicinal Chemistry (2019) Vol. 186, pp. 111896-111896
Open Access | Times Cited: 16
Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment
Mahmoud F. Abo-Ashour, Hadia Almahli, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2256-2264
Open Access | Times Cited: 9
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors
Davide Moi, Serena Vittorio, Andrea Angeli, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 91-91
Open Access | Times Cited: 9
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors
Vikas Sharma, Lalit Vats, Simone Giovannuzzi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 8
Closed Access | Times Cited: 1
Synthesis and biological evaluation of sulfamate derivatives as inhibitors of carbonic anhydrases II and IX
Saquib Jalil, Saif Ullah, Seyed–Omar Zaraei, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 5, pp. 869-883
Closed Access | Times Cited: 4
Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate
Begüm Nurpelin Sağlık, Derya Osmani̇ye, Ulviye Acar Çevik, et al.
European Journal of Medicinal Chemistry (2020) Vol. 198, pp. 112392-112392
Closed Access | Times Cited: 11
Lewis Base‐Catalyzed Cycloaddition of Heterocyclic Alkenes with 2,2,2‐Trifluorodiazoethane (CF3CHN2): Access to Trifluoromethylated Pyrazolines and Pyrazoles
Tingting Cao, Zhen Yang, Yunfang Sun, et al.
European Journal of Organic Chemistry (2021) Vol. 2021, Iss. 21, pp. 2950-2954
Closed Access | Times Cited: 9
Design, Synthesis and Biological Screening of Novel 1,5-Diphenyl-3-(4-(trifluoromethyl)phenyl)-2-pyrazoline Derivatives
Fatih Tok, Bedia Koçyiğit‐Kaymakçıoğlu
Acta chimica slovenica (2020) Vol. 67, Iss. 4, pp. 1139-1147
Open Access | Times Cited: 8
An Update on the Synthesis and Pharmacological Properties of Pyrazoles Obtained from Chalcone
Jaqueline E. Queiroz, Lucas D. Dias, Giuliana Muniz Vila Verde, et al.
Current Organic Chemistry (2022) Vol. 26, Iss. 2, pp. 81-90
Closed Access | Times Cited: 5
Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents
Kaan Küçükoğlu, Nagihan Faydalı, Dilek Bul, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134699-134699
Closed Access | Times Cited: 5
Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide Derivatives Bearing a Sulfonamide Moiety Show Single-digit Nanomolar-to-Subnanomolar Inhibition Constants against the Tumor-associated Human Carbonic Anhydrases IX and XII
Priya Hargunani, Nikhil Tadge, Mariangela Ceruso, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2621-2621
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top